OpGen Reports Third Quarter 2022 Financial Results and Provides Business Update
Completes first two commercial customer installations for Acuitas AMR Gene Panel OpGen subsidiary, Curetis, signed collaboration agreement with BioVersys AG and R&D collaboration agreement with FIND for the Unyvero A30 RQ platform Elects Yvonne …